Skip to content
Parakho

Take Ltd

NSE TAKEBSE 532890

Q1 FY27, unaudited

Revenue
₹11.97 Cr
Profit after tax
₹0.97 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations11.97—0.00
Other income1.33+22,030.00%6.62
Total income13.30+2,21,513.33%6.62
Employee benefit expense0.07−45.59%0.42
Finance costs0.00−99.53%0.29
Depreciation & amortisation0.00−90.00%0.01
Total expenses12.33+467.87%3.75
Profit before tax0.97+144.73%2.87
Tax expense0.00—0.16
Profit after tax0.97+144.73%2.72
Total comprehensive income0.97+144.73%2.72
Earnings per share
Earnings per share, basic₹0.07₹0.18
Earnings per share, diluted₹0.07₹0.18

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Take Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 38 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Research, Analytics & Technology

Classification as published by BSE.

Companies also in Healthcare Research, Analytics & Technology, in alphabetical order

All 11 companies in Healthcare Research, Analytics & Technology

Page generated from filings held to 01 Oct 2026.